Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harrow Inc
(NQ:
HROW
)
38.92
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harrow Inc
< Previous
1
2
3
4
5
6
7
Next >
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Harrow Health, Inc. and Encourages Investors with Losses to Contact the Firm
February 22, 2023
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation – HROW, HROWL, HROWM
February 22, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Harrow Launches Next-Generation Compounded Atropine Formulations
February 15, 2023
From
Harrow
Via
Business Wire
FDA Approves First Branded Ocular Anesthetic In Almost 14 Years
September 28, 2022
Via
Benzinga
Harrow Announces Permanent, Product-Specific J-Code (J2403) for IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia Effective April 1, 2023
February 02, 2023
From
Harrow
Via
Business Wire
Harrow Closes Acquisition of U.S. Rights to ILEVRO®, NEVANAC®, VIGAMOX®, MAXIDEX®, and TRIESENCE® and Will Begin Receiving Net Profit Payments for Acquired Products
January 23, 2023
From
Harrow
Via
Business Wire
Harrow Announces Availability of Fortisite™ Formulations for In-Office Use
January 05, 2023
From
Harrow Health, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
December 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Melt Pharmaceuticals’ MELT-300 (Midazolam 3mg and Ketamine 50mg Sublingual Tablet) Achieves Primary Sedation Endpoint in Phase 2 Pivotal Efficacy and Safety Study
December 21, 2022
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Harrow Secures Capital to Close Recently Announced Acquisition
December 16, 2022
From
Harrow Health, Inc.
Via
Business Wire
$10 Million Bet On Dyne Therapeutics? Check Out These 4 Stocks Insiders Are Buying
December 15, 2022
Although US stocks closed lower on Wednesday following Fed’s rate decision, there were a few notable insider trades.
Via
Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday
December 14, 2022
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones
December 14, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Prices $25 Million Offering
December 14, 2022
From
Harrow
Via
Business Wire
Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO®, NEVANAC®, VIGAMOX®, MAXIDEX®, and TRIESENCE®
December 14, 2022
From
Harrow
Via
Business Wire
Harrow and iOR Partners Expand National Product Supply Agreement
November 30, 2022
From
Harrow
Via
Business Wire
Harrow Announces Third Quarter 2022 Financial Results
November 14, 2022
From
Harrow
Via
Business Wire
Harrow Launches Atropine.com
November 10, 2022
From
Harrow
Via
Business Wire
Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022
October 28, 2022
From
Harrow
Via
Business Wire
Melt Pharmaceuticals Announces Dosing of Last Patient in Phase 2 Pivotal Efficacy and Safety Study for MELT-300
October 27, 2022
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
NGM Biopharmaceuticals, Fox Corporation And Some Other Big Stocks Moving Lower On Monday
October 17, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Harrow Sells Non-Ophthalmic Compounding Business
October 05, 2022
From
Harrow
Via
Business Wire
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
September 30, 2022
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 29, 2022
Gainers
Via
Benzinga
ImprimisRx Launches Fortisite™ (Tobramycin 1.5% + Vancomycin 5%) Compounded Antibiotic Formulation
September 29, 2022
From
Harrow
Via
Business Wire
Ryder System, Harrow Health And Other Big Gainers From Tuesday
September 28, 2022
U.S. stocks closed mixed with the Dow Jones dropping around 125 points on Tuesday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
September 27, 2022
From
Harrow
Via
Business Wire
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Gainers
Via
Benzinga
Harrow Health to Participate in H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
August 11, 2022
From
Harrow Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.